<p>— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an
<p>ATLANTA, Jan. 31, 2022 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) will host a conference call on Wednesday, February 23rd at 4:30 PM ET to discuss its fourth quarter and full
Leave a Comment